JWA
USNA icon

JFS Wealth Advisors’s Usana Health Sciences USNA Stock Holding History

JFS Wealth Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$108 – 2035
2023
Q4 		$108 Sell
2
-1
-33% -$51 ﹤0.01% 1952
2023
Q3 		$176 Hold
3
– – ﹤0.01% 1875
2023
Q2 		$190 Sell
3
-2
-40% -$127 ﹤0.01% 1881
2023
Q1 		$315 Buy
5
+1
+25% +$60 ﹤0.01% 1775
2022
Q4 		$213 Buy
4
+2
+100% +$108 ﹤0.01% 1826
2022
Q3 		$0 Sell
2
-3
-60% -$198 ﹤0.01% 1935
2022
Q2 		$0 Buy
5
+2
+67% +$149 ﹤0.01% 1944
2022
Q1 		$0 Buy
3
+1
+50% +$90 ﹤0.01% 1974
2021
Q4 		$0 Buy
+2
New +$200 ﹤0.01% 1889

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JFS Wealth Advisors's USNA Position: Q1 2024 in Review

JFS Wealth Advisors sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 2 shares — an estimated $108 sold.

JFS Wealth Advisors first reported a position in USNA in Q4 2021 and held it in 9 quarters. The position peaked at $315 in Q1 2023. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

  • JFS Wealth Advisors reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
  • JFS Wealth Advisors sold 2 Usana Health Sciences shares in Q1 2024, an estimated $108.
  • JFS Wealth Advisors first reported a position in Usana Health Sciences in Q4 2021 and held it in 9 quarters.
  • JFS Wealth Advisors's Usana Health Sciences position peaked at $315 in Q1 2023.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on JFS Wealth Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.